Wyeth Investors Win Class Cert. In Suit Over Pristiq Risks

Law360, New York (September 18, 2012, 4:51 PM EDT) -- A New York federal judge on Tuesday granted class certification to a group of investors accusing Pfizer Inc. unit Wyeth Pharmaceuticals Inc. of failing to disclose serious side effects associated with the antidepressant Pristiq.

The order comes four months after U.S. District  Judge Richard S. Sullivan indicated in a hearing that he would certify the class, which is led by a pipe fitters union and alleges that Wyeth, as an independent company in 2006, committed securities fraud by failing to disclose heart- and liver-related side effects...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

City of Livonia Employees' Retirement System v. Essner et al


Case Number

1:07-cv-10329

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Richard J. Sullivan

Date Filed

November 13, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.